NYSE:CPHI China Pharma (CPHI) Stock Price, News & Analysis $0.87 -0.09 (-9.32%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$0.87 0.00 (-0.29%) As of 10/9/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsNews and TrendsOwnershipSEC Filings About China Pharma Stock (NYSE:CPHI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get China Pharma alerts:Sign Up Key Stats Today's Range$0.80▼$1.0950-Day Range$0.64▼$1.2652-Week Range$0.38▼$19.19Volume2.18 million shsAverage Volume2.05 million shsMarket Capitalization$37.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview China Pharma Holdings, Inc. is a pharmaceutical company based in Harbin, China. Through its operating subsidiaries, the company develops, manufactures and markets pharmaceutical products for the Chinese healthcare market. Its product portfolio has included prescription medicines, over-the-counter drugs, antibiotics, cardiovascular treatments, biopharmaceutical products and traditional Chinese medicines. The company has also offered pharmaceutical products used in hospitals and other healthcare settings, as well as certain nutritional and health-related products. China Pharma primarily serves customers in China through pharmaceutical distribution channels and healthcare institutions. Publicly available company information is limited, so detailed current information about its product lineup, geographic reach and leadership should be confirmed through the company’s latest regulatory filings.AI Generated. May Contain Errors. Read More Receive CPHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPHI Stock News HeadlinesIndian SME pharma firms see shift of orders from China; cost, quality concerns remainOctober 6, 2026 | msn.comChina Pharma (NYSE:CPHI) Stock Jumps 1% - Time to Buy?October 1, 2026 | americanbankingnews.comFirst Look: Elon’s “Starphone”Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.October 10 at 1:00 AM | Stansberry Research (Ad)China Pharma Holdings IncSeptember 4, 2026 | markets.ft.comChina Pharma Holdings, Inc.: China Pharma Announces Pricing of $5 Million Registered Direct OfferingJuly 24, 2026 | finanznachrichten.deChina Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct OfferingJuly 23, 2026 | prnewswire.comChina Pharma Holdings Announces New Capital Raising AgreementJuly 22, 2026 | tipranks.comChina Pharma Announces Pricing of $5 Million Registered Direct OfferingJuly 22, 2026 | prnewswire.comSee More Headlines CPHI Stock Analysis - Frequently Asked Questions How have CPHI shares performed this year? China Pharma's stock was trading at $1.21 at the start of the year. Since then, CPHI shares have decreased by 28.1% and is now trading at $0.8705. How were China Pharma's earnings last quarter? China Pharma Holdings, Inc. (NYSE:CPHI) announced its quarterly earnings data on Wednesday, August, 15th. The company reported ($100.00) earnings per share (EPS) for the quarter. The firm had revenue of $3.17 million for the quarter. China Pharma had a negative net margin of 85.56% and a negative trailing twelve-month return on equity of 63.93%. When did China Pharma's stock split? China Pharma's stock reverse split before market open on Tuesday, April 15th 2025.The 1-10 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of China Pharma? Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of China Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that China Pharma investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and Bionano Genomics (BNGO). Company Calendar Last Earnings8/15/2018Today10/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CPHI's financial health is in the Red zone, according to TradeSmith. CPHI has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:CPHI CIK1106644 Webwww.chinapharmaholdings.com Phone8689866811730Fax86-898-6681-9024Employees221Year Founded1999Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.08 million Net Margins-85.56% Pretax Margin-85.56% Return on Equity-63.93% Return on Assets-31.42% Debt Debt-to-Equity Ratio0.22 Current Ratio0.79 Quick Ratio0.26 Sales & Book Value Annual Sales$3.91 million Price / Sales9.57 Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / Book1.24Miscellaneous Outstanding Shares43,022,000Free Float15,918,000Market Cap$37.45 million OptionableNot Optionable Beta1.04 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:CPHI) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredTech expert smashes iPhone with golf clubTwenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...Stansberry Research | SponsoredElon’s Hiding a Potential $20 Trillion Monster Inside TeslaElon Musk says there is a product inside Tesla's factories he calls the biggest ever made, ten times bigger th...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
